SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 126.95 |
| Enterprise Value ($M) | 378.11 |
| Book Value ($M) | -136.21 |
| Book Value / Share | -1.17 |
| Price / Book | -0.93 |
| NCAV ($M) | -142.72 |
| NCAV / Share | -1.23 |
| Price / NCAV | -0.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.83 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.32 |
| Current Ratio | 3.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 233.92 |
| Assets | 240.44 |
| Liabilities | 376.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 146.03 |
| Operating Income | -129.54 |
| Net Income | -143.10 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -92.72 |
| Cash from Investing | 7.94 |
| Cash from Financing | 1.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Palo Alto Investors LP | 4.45 | -9.79 | |
| 13G/A | Avidity Partners Management LP | 9.50 | -1.69 | |
| 13G | Vanguard Group Inc | 7.60 | ||
| 13G/A | Rubric Capital Management LP | 0.00 | -100.00 | |
| 13G/A | BlackRock Inc. | 8.80 | 18.38 | |
| 13G/A | State Street Corp | 1.79 | -7.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 194,142 | 565,028 | 34.36 | |
| 479,993 | 187,968 | 255.36 | |
| 490,713 | 228,139 | 215.09 | |
| 342,548 | 119,122 | 287.56 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JAZZ – Jazz Pharmaceuticals plc | KMDA – Kamada Ltd. |
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KRON – Kronos Bio, Inc. |
| KRYS – Krystal Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io